Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol at different anesthesia depths for percutaneous microballoon compression
ChiCTR2100049775Phase 4Not yet recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in trigeminal neuralgia (TN) (4 arms), sponsored by The Second Xiangya Hospital. Primary endpoint: Hemodynamics. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on ChiCTR2100049775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049775.